Rincell-1
AssetCell therapy
Otic neural progenitor cell therapy to replace damaged auditory neurons and restore hearing function
- Stage
- Phase 1
- Modality
- Cell therapy
- Target
- Stem cell maintenance
- Indications
- 3
- Trials
- 1
- Developers
- 1
Indications
3Auditory neuropathy
Phase 1NOT_YET_RECRUITINGNCT07032038clinicaltrials.gov7 Oct 2026
Presbyacusis
Phase 1NOT_YET_RECRUITINGNCT07032038clinicaltrials.gov7 Oct 2026
Sensorineural hearing loss
Phase 1NOT_YET_RECRUITINGNCT07032038clinicaltrials.gov7 Oct 2026
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 1 source